|
1 |
11 08 2025 |
No further extension of deadline for online submission of WHO-GMP COPP applications: DCGI |
Pharmabiz |
India |
|
2 |
11 08 2025 |
Ayush and herbal products exports report growth of 0.6% in Q1 FY26 |
Pharmabiz |
India |
|
3 |
11 08 2025 |
Urgent need for standardization in dental education and clinical practices: Dr Ashok Dhoble |
Pharmabiz |
India |
|
4 |
11 08 2025 |
Egypt steps up support for pharmaceutical industry development |
Tv Brics |
Egypt |
|
5 |
11 08 2025 |
Laborate Pharma secures EU-GMP certification,Expands Global supply chain capabilities |
Medical Dialogues |
India |
|
6 |
11 08 2025 |
No Life-saving drug category in India, Govt. Clarifies as 930 medicines remain under price control |
Medical Dialogues |
India |
|
7 |
09 08 2025 |
Gujarat attracts big ticket investments from Rs. 100 crore to 5,000 crore from MNCs & Indian companies |
Pharmabiz |
India |
|
8 |
09 08 2025 |
Health ministry releases recruitment rules for Deputy Drugs Controller |
Pharmabiz |
India |
|
9 |
09 08 2025 |
AIOCD vehemently opposes Karnataka govt's proposal to implement third-party inspections of pharmacies |
Pharmabiz |
India |
|
10 |
09 08 2025 |
NPPA slapped Rs.9950 Cr penalty on Pharma Firms, Recovered only 14.25% |
Medical Dialogues |
India |
|
11 |
09 08 2025 |
Iberia Pharmaceuticals Announces ₹70-Crore State-of-the-Art Manufacturing & Research Facility in Haryana |
E HEALTH |
India |
|
12 |
09 08 2025 |
Pharmexcil welcomes tariff exemptions for pharma sector |
Business Line |
India |
|
13 |
09 08 2025 |
CDSCO panel approves New Indications for Novo Nordisk's Semaglutide, Mandates PMS study |
Medical Dialogues |
India |
|
14 |
09 08 2025 |
Indian Pharma Market registers 7.9 percents growth in July : Report |
Medical Dialogues |
India |
|
15 |
08 08 2025 |
Indian Pharma Tariffs Burden US Consumers: Pharmexcil |
Money Rediff |
India |
|
16 |
08 08 2025 |
CDSCO Committe asks Elevate scientific to prove back pain gel in Indian Trail |
Medical Dialogues |
India |
|
17 |
08 08 2025 |
NO Ban on Paracetamol ,says Government ;156 Drug combos Axed over safety concerns |
Medical Dialogues |
India |
|
18 |
08 08 2025 |
Karnataka reduces withdrawal timeline for NSQ drugs from 30 days to just 3 days |
Pharmabiz |
India |
|
19 |
08 08 2025 |
NPPA accepts MDC's decision to reject Dr Reddy's application on separate price for Omaze ODT |
Pharmabiz |
India |
|
20 |
08 08 2025 |
Goa PMRU reports 38 per cent drop in drug overcharging cases |
Pharmabiz |
India |
